321 related articles for article (PubMed ID: 33755690)
21. Transcriptome profiling reveals the complexity of pirfenidone effects in idiopathic pulmonary fibrosis.
Kwapiszewska G; Gungl A; Wilhelm J; Marsh LM; Thekkekara Puthenparampil H; Sinn K; Didiasova M; Klepetko W; Kosanovic D; Schermuly RT; Wujak L; Weiss B; Schaefer L; Schneider M; Kreuter M; Olschewski A; Seeger W; Olschewski H; Wygrecka M
Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30166321
[TBL] [Abstract][Full Text] [Related]
22. Fibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype.
Epstein Shochet G; Wollin L; Shitrit D
Respirology; 2018 Aug; 23(8):756-763. PubMed ID: 29532550
[TBL] [Abstract][Full Text] [Related]
23. Central lung gene expression associates with myofibroblast features in idiopathic pulmonary fibrosis.
Huang Y; Guzy R; Ma SF; Bonham CA; Jou J; Schulte JJ; Kim JS; Barros AJ; Espindola MS; Husain AN; Hogaboam CM; Sperling AI; Noth I
BMJ Open Respir Res; 2023 Feb; 10(1):. PubMed ID: 36725082
[TBL] [Abstract][Full Text] [Related]
24. Transcriptomic profiling reveals disease-specific characteristics of epithelial cells in idiopathic pulmonary fibrosis.
Boesch M; Baty F; Brutsche MH; Tamm M; Roux J; Knudsen L; Gazdhar A; Geiser T; Khan P; Hostettler KE
Respir Res; 2020 Jun; 21(1):165. PubMed ID: 32605572
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of USP13 mediates phenotype transformation of fibroblasts in idiopathic pulmonary fibrosis.
Geng J; Huang X; Li Y; Xu X; Li S; Jiang D; Liang J; Jiang D; Wang C; Dai H
Respir Res; 2015 Oct; 16():124. PubMed ID: 26453058
[TBL] [Abstract][Full Text] [Related]
26. Unsupervised gene expression analyses identify IPF-severity correlated signatures, associated genes and biomarkers.
Wang Y; Yella J; Chen J; McCormack FX; Madala SK; Jegga AG
BMC Pulm Med; 2017 Oct; 17(1):133. PubMed ID: 29058630
[TBL] [Abstract][Full Text] [Related]
27. Fibrocytes are increased in lung and peripheral blood of patients with idiopathic pulmonary fibrosis.
Heukels P; van Hulst JAC; van Nimwegen M; Boorsma CE; Melgert BN; van den Toorn LM; Boomars KAT; Wijsenbeek MS; Hoogsteden H; von der Thüsen JH; Hendriks RW; Kool M; van den Blink B
Respir Res; 2018 May; 19(1):90. PubMed ID: 29747640
[TBL] [Abstract][Full Text] [Related]
28. miR-34 miRNAs Regulate Cellular Senescence in Type II Alveolar Epithelial Cells of Patients with Idiopathic Pulmonary Fibrosis.
Disayabutr S; Kim EK; Cha SI; Green G; Naikawadi RP; Jones KD; Golden JA; Schroeder A; Matthay MA; Kukreja J; Erle DJ; Collard HR; Wolters PJ
PLoS One; 2016; 11(6):e0158367. PubMed ID: 27362652
[TBL] [Abstract][Full Text] [Related]
29. Integrated plasma proteomics and lung transcriptomics reveal novel biomarkers in idiopathic pulmonary fibrosis.
Sivakumar P; Ammar R; Thompson JR; Luo Y; Streltsov D; Porteous M; McCoubrey C; Cantu E; Beers MF; Jarai G; Christie JD
Respir Res; 2021 Oct; 22(1):273. PubMed ID: 34689792
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of mast cells: a novel mechanism by which nintedanib may elicit anti-fibrotic effects.
Overed-Sayer C; Miranda E; Dunmore R; Liarte Marin E; Beloki L; Rassl D; Parfrey H; Carruthers A; Chahboub A; Koch S; Güler-Gane G; Kuziora M; Lewis A; Murray L; May R; Clarke D
Thorax; 2020 Sep; 75(9):754-763. PubMed ID: 32709610
[TBL] [Abstract][Full Text] [Related]
31. CC Chemokines in Idiopathic Pulmonary Fibrosis: Pathogenic Role and Therapeutic Potential.
Liu S; Liu C; Wang Q; Liu S; Min J
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830702
[TBL] [Abstract][Full Text] [Related]
32. Global Gene Expression Analysis in an in vitro Fibroblast Model of Idiopathic Pulmonary Fibrosis Reveals Potential Role for CXCL14/CXCR4.
Rodriguez LR; Emblom-Callahan M; Chhina M; Bui S; Aljeburry B; Tran LH; Novak R; Lemma M; Nathan SD; Grant GM
Sci Rep; 2018 Mar; 8(1):3983. PubMed ID: 29507348
[TBL] [Abstract][Full Text] [Related]
33. Multiplatform Single-Cell Analysis Identifies Immune Cell Types Enhanced in Pulmonary Fibrosis.
Serezani APM; Pascoalino BD; Bazzano JMR; Vowell KN; Tanjore H; Taylor CJ; Calvi CL; McCall AS; Bacchetta MD; Shaver CM; Ware LB; Salisbury ML; Banovich NE; Kendall PL; Kropski JA; Blackwell TS
Am J Respir Cell Mol Biol; 2022 Jul; 67(1):50-60. PubMed ID: 35468042
[TBL] [Abstract][Full Text] [Related]
34. Lung fibroblasts from patients with idiopathic pulmonary fibrosis exhibit genome-wide differences in DNA methylation compared to fibroblasts from nonfibrotic lung.
Huang SK; Scruggs AM; McEachin RC; White ES; Peters-Golden M
PLoS One; 2014; 9(9):e107055. PubMed ID: 25215577
[TBL] [Abstract][Full Text] [Related]
35. Defining the Activated Fibroblast Population in Lung Fibrosis Using Single-Cell Sequencing.
Peyser R; MacDonnell S; Gao Y; Cheng L; Kim Y; Kaplan T; Ruan Q; Wei Y; Ni M; Adler C; Zhang W; Devalaraja-Narashimha K; Grindley J; Halasz G; Morton L
Am J Respir Cell Mol Biol; 2019 Jul; 61(1):74-85. PubMed ID: 30848683
[TBL] [Abstract][Full Text] [Related]
36. Increased FGF1-FGFRc expression in idiopathic pulmonary fibrosis.
MacKenzie B; Korfei M; Henneke I; Sibinska Z; Tian X; Hezel S; Dilai S; Wasnick R; Schneider B; Wilhelm J; El Agha E; Klepetko W; Seeger W; Schermuly R; Günther A; Bellusci S
Respir Res; 2015 Jul; 16(1):83. PubMed ID: 26138239
[TBL] [Abstract][Full Text] [Related]
37. NFATc3 and VIP in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease.
Szema AM; Forsyth E; Ying B; Hamidi SA; Chen JJ; Hwang S; Li JC; Sabatini Dwyer D; Ramiro-Diaz JM; Giermakowska W; Gonzalez Bosc LV
PLoS One; 2017; 12(1):e0170606. PubMed ID: 28125639
[TBL] [Abstract][Full Text] [Related]
38. Safety and effectiveness of pirfenidone combined with carboplatin-based chemotherapy in patients with idiopathic pulmonary fibrosis and non-small cell lung cancer: A retrospective cohort study.
Yamamoto Y; Yano Y; Kuge T; Okabe F; Ishijima M; Uenami T; Kanazu M; Akazawa Y; Yamaguchi T; Mori M
Thorac Cancer; 2020 Nov; 11(11):3317-3325. PubMed ID: 32986306
[TBL] [Abstract][Full Text] [Related]
39. Fibrosis: Lessons from OMICS analyses of the human lung.
Yu G; Ibarra GH; Kaminski N
Matrix Biol; 2018 Aug; 68-69():422-434. PubMed ID: 29567123
[TBL] [Abstract][Full Text] [Related]
40. Interferon-γ enhances the antifibrotic effects of pirfenidone by attenuating IPF lung fibroblast activation and differentiation.
Vu TN; Chen X; Foda HD; Smaldone GC; Hasaneen NA
Respir Res; 2019 Sep; 20(1):206. PubMed ID: 31511015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
